Myeloid sarcoma and pathological fracture: a case report and review of literature

Int J Hematol. 2023 Dec;118(6):745-750. doi: 10.1007/s12185-023-03656-1. Epub 2023 Sep 14.

Abstract

Myeloid sarcoma is a rare clinical entity that presents as an isolated proliferation of leukemic cells, concurrently with or at relapse of acute myeloid leukemia (AML), myelodysplastic syndromes/neoplasms (MDS), chronic myeloid leukemia (CML), and myeloproliferative neoplasm (MPN). Myeloid sarcoma disrupts the normal architecture of its surrounding tissues. When it forms in long bones, it can cause their pathological fracture. We recently experienced a rare case of MDS presenting with myeloid sarcoma in the femur that eventually resulted in its pathological fracture. Detailed chromosomal analysis of the bone marrow cells suggested emergence of myeloid sarcoma during the fast-paced progression of MDS just after acquiring trisomy 22. A comprehensive review of previous cases of myeloid sarcoma-associated pathological fracture indicated possible involvement of structural rearrangements of chromosomes 9 and 22. Management of myeloid sarcoma should continue to improve, and clinicians should note that myeloid sarcoma with specific chromosomal alterations needs extra medical attention to prevent pathological fracture.

Keywords: Myelodysplastic syndromes/neoplasms; Myeloid sarcoma; Pathological fracture.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Fractures, Spontaneous* / etiology
  • Humans
  • Leukemia, Myeloid, Acute* / genetics
  • Myelodysplastic Syndromes* / genetics
  • Myeloproliferative Disorders* / genetics
  • Sarcoma, Myeloid* / genetics
  • Sarcoma, Myeloid* / pathology